Disclosure of Financial Relationship

It is the policy of the Binaytara Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its direct or jointly provided educational programs. Conflicts of interest develop when an individual has an opportunity to affect Continuing Education (CE) content, introducing or promoting products or services of an ineligible company (formerly commercial interest) with which he/she has a relevant financial relationship.

ACCME definition of an ineligible company: Companies that are ineligible to be accredited in the ACCME System (ineligible companies) are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Examples of such organizations include:

• Advertising, marketing, or communication firms whose clients are ineligible companies
• Bio-medical startups that have begun a governmental regulatory approval process
  Compounding pharmacies that manufacture proprietary compounds
• Device manufacturers or distributors                              
• Diagnostic labs that sell proprietary products
• Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
• Manufacturers of health-related wearable products
• Pharmaceutical companies or distributors
• Pharmacy benefit managers
• Reagent manufacturers or sellers

The existence of any relevant financial interest or other relationship a faculty member currently has, or has had within the last 24 -months with the commercial supporter(s) of this educational activity or with an ineligible company as defined above, shall be disclosed.

The intent of this policy is to openly identify any such relationships so that a) Binaytara Foundation can identify any conflict of interest that may exist, and b) so that learners may form their own opinions as to whether the speaker's presentation reflects possible bias in either exposition or conclusion. The existence of any such financial interests or relationships shall be disclosed to participants prior to educational activities in brief statements, in conference materials such as brochures, syllabi, exhibits, and poster sessions, and in post-meeting publications. 

The purpose of this form is to identify and mitigate all potential conflicts of interest that arise from financial relationships with any commercial or proprietary entity relevant to the content you are planning, developing, or presenting for this activity. 

Disclosure of Unlabeled/Investigational Uses of Products

Faculty shall disclose when an unlabeled use of a commercial product, or an investigational use not yet approved for any purpose, is discussed during an educational activity.  Faculty shall disclose that the product is not labeled for the use under discussion or that the product is still investigational. 
The intent of this policy is not to prohibit or limit the exchange of views in scientific and educational discussions, including discussions of unapproved uses, but to ensure that faculty disclose to participants that such discussion will take place.
It is standard procedure of the Binaytara Foundation to acknowledge the type of disclosure - i.e., nothing to disclose, affiliation(s) and/or financial interest(s) disclosed, that unapproved or investigational uses of products will be discussed, and failure of faculty to make disclosure by the established deadline.  Failure to disclose or false disclosure may result in disqualification from participation, and may require the Binaytara Foundation to identify a replacement for faculty.

I have read the Binaytara Foundation policy on full disclosure.  If I have indicated a relevant financial relationship, or if I will discuss unapproved or investigational uses of products or devices, I understand that I am responsible for disclosing this information to participants at the beginning of my presentation/material.  I understand that failure to disclose or false disclosure may require the Binaytara Foundation to identify a replacement for my participation or revoke CE eligibility.